Recoflavone Completed Phase 1 Trials for Dry Eye Syndrome (DES) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01162954Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers